IDAHO STRATEGIC RESOURCES IN (IDR)

US6458272050 - Common Stock

10.04  0 (0%)

Fundamental Rating

7

Overall IDR gets a fundamental rating of 7 out of 10. We evaluated IDR against 155 industry peers in the Metals & Mining industry. IDR is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. IDR is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings could make IDR a good candidate for growth investing.



6

1. Profitability

1.1 Basic Checks

IDR had positive earnings in the past year.
IDR had a positive operating cash flow in the past year.
In the past 5 years IDR reported 4 times negative net income.
In multiple years IDR reported negative operating cash flow during the last 5 years.

1.2 Ratios

The Return On Assets of IDR (15.84%) is better than 95.48% of its industry peers.
IDR's Return On Equity of 20.09% is amongst the best of the industry. IDR outperforms 91.61% of its industry peers.
IDR has a Return On Invested Capital of 12.83%. This is amongst the best in the industry. IDR outperforms 90.32% of its industry peers.
Industry RankSector Rank
ROA 15.84%
ROE 20.09%
ROIC 12.83%
ROA(3y)-8.29%
ROA(5y)-6.97%
ROE(3y)-13.86%
ROE(5y)-12.02%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin of IDR (26.69%) is better than 94.84% of its industry peers.
IDR's Profit Margin has declined in the last couple of years.
The Operating Margin of IDR (25.87%) is better than 86.45% of its industry peers.
With an excellent Gross Margin value of 43.02%, IDR belongs to the best of the industry, outperforming 84.52% of the companies in the same industry.
IDR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 25.87%
PM (TTM) 26.69%
GM 43.02%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-18%
GM growth 3Y190.01%
GM growth 5YN/A

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so IDR is still creating some value.
The number of shares outstanding for IDR has been increased compared to 1 year ago.
Compared to 5 years ago, IDR has more shares outstanding
The debt/assets ratio for IDR has been reduced compared to a year ago.

2.2 Solvency

IDR has an Altman-Z score of 12.97. This indicates that IDR is financially healthy and has little risk of bankruptcy at the moment.
IDR's Altman-Z score of 12.97 is amongst the best of the industry. IDR outperforms 81.94% of its industry peers.
IDR has a debt to FCF ratio of 0.92. This is a very positive value and a sign of high solvency as it would only need 0.92 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.92, IDR belongs to the best of the industry, outperforming 86.45% of the companies in the same industry.
IDR has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of IDR (0.08) is better than 61.94% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.92
Altman-Z 12.97
ROIC/WACC1.16
WACC11.05%

2.3 Liquidity

A Current Ratio of 6.01 indicates that IDR has no problem at all paying its short term obligations.
IDR has a better Current ratio (6.01) than 84.52% of its industry peers.
IDR has a Quick Ratio of 5.58. This indicates that IDR is financially healthy and has no problem in meeting its short term obligations.
IDR has a Quick ratio of 5.58. This is amongst the best in the industry. IDR outperforms 83.87% of its industry peers.
Industry RankSector Rank
Current Ratio 6.01
Quick Ratio 5.58

9

3. Growth

3.1 Past

IDR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 492.31%, which is quite impressive.
IDR shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.12% yearly.
The Revenue has grown by 42.55% in the past year. This is a very strong growth!
Measured over the past years, IDR shows a very strong growth in Revenue. The Revenue has been growing by 30.34% on average per year.
EPS 1Y (TTM)492.31%
EPS 3YN/A
EPS 5Y-0.12%
EPS Q2Q%400%
Revenue 1Y (TTM)42.55%
Revenue growth 3Y34.01%
Revenue growth 5Y30.34%
Sales Q2Q%86.39%

3.2 Future

Based on estimates for the next years, IDR will show a very strong growth in Earnings Per Share. The EPS will grow by 192.04% on average per year.
Based on estimates for the next years, IDR will show a very strong growth in Revenue. The Revenue will grow by 44.51% on average per year.
EPS Next Y752.89%
EPS Next 2Y192.04%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year99.26%
Revenue Next 2Y44.51%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 19.69 indicates a rather expensive valuation of IDR.
Compared to the rest of the industry, the Price/Earnings ratio of IDR indicates a somewhat cheap valuation: IDR is cheaper than 65.16% of the companies listed in the same industry.
IDR's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.30.
The Price/Forward Earnings ratio is 13.08, which indicates a correct valuation of IDR.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IDR indicates a somewhat cheap valuation: IDR is cheaper than 63.23% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.80. IDR is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 19.69
Fwd PE 13.08

4.2 Price Multiples

IDR's Enterprise Value to EBITDA ratio is in line with the industry average.
IDR's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. IDR is cheaper than 63.23% of the companies in the same industry.
Industry RankSector Rank
P/FCF 46.15
EV/EBITDA 18.73

4.3 Compensation for Growth

IDR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of IDR may justify a higher PE ratio.
A more expensive valuation may be justified as IDR's earnings are expected to grow with 192.04% in the coming years.
PEG (NY)0.03
PEG (5Y)N/A
EPS Next 2Y192.04%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for IDR!.
Industry RankSector Rank
Dividend Yield N/A

IDAHO STRATEGIC RESOURCES IN

NYSEARCA:IDR (12/27/2024, 8:04:01 PM)

10.04

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-04 2024-11-04/bmo
Earnings (Next)N/A N/A
Inst Owners14.52%
Inst Owner Change46.72%
Ins Owners5.92%
Ins Owner Change-18.86%
Market Cap137.15M
Analysts80
Price Target16.83 (67.63%)
Short Float %3.87%
Short Ratio1.7
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)160.49%
Min EPS beat(2)140.45%
Max EPS beat(2)180.53%
EPS beat(4)3
Avg EPS beat(4)114.4%
Min EPS beat(4)-60.4%
Max EPS beat(4)197.03%
EPS beat(8)5
Avg EPS beat(8)-97.25%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)17.91%
Min Revenue beat(2)16.62%
Max Revenue beat(2)19.2%
Revenue beat(4)3
Avg Revenue beat(4)7.57%
Min Revenue beat(4)-6.61%
Max Revenue beat(4)19.2%
Revenue beat(8)5
Avg Revenue beat(8)-2.53%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)65%
EPS NQ rev (1m)0%
EPS NQ rev (3m)5%
EPS NY rev (1m)0%
EPS NY rev (3m)171.43%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)32.84%
Valuation
Industry RankSector Rank
PE 19.69
Fwd PE 13.08
P/S 7.18
P/FCF 46.15
P/OCF 22.23
P/B 5.4
P/tB 5.4
EV/EBITDA 18.73
EPS(TTM)0.51
EY5.08%
EPS(NY)0.77
Fwd EY7.65%
FCF(TTM)0.22
FCFY2.17%
OCF(TTM)0.45
OCFY4.5%
SpS1.4
BVpS1.86
TBVpS1.86
PEG (NY)0.03
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 15.84%
ROE 20.09%
ROCE 16.24%
ROIC 12.83%
ROICexc 17.53%
ROICexgc 17.53%
OM 25.87%
PM (TTM) 26.69%
GM 43.02%
FCFM 15.56%
ROA(3y)-8.29%
ROA(5y)-6.97%
ROE(3y)-13.86%
ROE(5y)-12.02%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-18%
GM growth 3Y190.01%
GM growth 5YN/A
F-Score8
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.92
Debt/EBITDA 0.3
Cap/Depr 182.42%
Cap/Sales 16.74%
Interest Coverage 250
Cash Conversion 92.16%
Profit Quality 58.29%
Current Ratio 6.01
Quick Ratio 5.58
Altman-Z 12.97
F-Score8
WACC11.05%
ROIC/WACC1.16
Cap/Depr(3y)248.59%
Cap/Depr(5y)207.8%
Cap/Sales(3y)26.27%
Cap/Sales(5y)21.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)492.31%
EPS 3YN/A
EPS 5Y-0.12%
EPS Q2Q%400%
EPS Next Y752.89%
EPS Next 2Y192.04%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)42.55%
Revenue growth 3Y34.01%
Revenue growth 5Y30.34%
Sales Q2Q%86.39%
Revenue Next Year99.26%
Revenue Next 2Y44.51%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y641.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y180.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y370.27%
OCF growth 3YN/A
OCF growth 5YN/A